SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes

Cell Reports

Volumn 16, Issue 9, 2016, Pages 2271-2280

  Kupka, Sebastian ^a   De Miguel, Diego ^a   Draber, Peter ^a   Martino, Luigi ^b   Surinova, Silvia ^a   Rittinger, Katrin ^b   Walczak, Henning ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; MEMBRANE PROTEIN; PROTEIN CYLD; PROTEIN HOIP; PROTEIN SPATA2; TUMOR NECROSIS FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYLD PROTEIN, HUMAN; NOD2 PROTEIN, HUMAN; PROTEIN; PROTEIN BINDING; RECOMBINANT PROTEIN; RNF31 PROTEIN, HUMAN; SPATA2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVATORY PATHWAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; MOLECULAR GENETICS; NECROPTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; HELA CELL LINE; HUMAN; MACROPHAGE; METABOLISM; MOLECULAR CLONING; MOUSE; PLASMID; PRIMARY CELL CULTURE;

ANIMALS; BINDING SITES; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MACROPHAGES; MICE; NOD2 SIGNALING ADAPTOR PROTEIN; PLASMIDS; PRIMARY CELL CULTURE; PROTEIN BINDING; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84990210741     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.07.086     Document Type: Article

References (42)

1. Biggs, P.J., Wooster, R., Ford, D., Chapman, P., Mangion, J., Quirk, Y., Easton, D.F., Burn, J., Stratton, M.R., Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat. Genet. 11 (1995), 441–443.
2. Brummelkamp, T.R., Nijman, S.M., Dirac, A.M., Bernards, R., Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424 (2003), 797–801.
3. Chen, Z.J., Sun, L.J., Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33 (2009), 275–286.
4. Damgaard, R.B., Nachbur, U., Yabal, M., Wong, W.W., Fiil, B.K., Kastirr, M., Rieser, E., Rickard, J.A., Bankovacki, A., Peschel, C., et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 46 (2012), 746–758.
5. Douanne, T., Gavard, J., Bidère, N., The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling. J. Cell Sci. 129 (2016), 1775–1780.
6. Draber, P., Kupka, S., Reichert, M., Draberova, H., Lafont, E., de Miguel, D., Spilgies, L., Surinova, S., Taraborrelli, L., Hartwig, T., et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13 (2015), 2258–2272.
7. Dubois, A., Wilson, V., Bourn, D., Rajan, N., CYLD Genetic testing for Brooke-Spiegler syndrome, familial cylindromatosis and multiple familial trichoepitheliomas. PLoS Curr., 7, 2015, 7.
8. Elliott, P.R., Nielsen, S.V., Marco-Casanova, P., Fiil, B.K., Keusekotten, K., Mailand, N., Freund, S.M., Gyrd-Hansen, M., Komander, D., Molecular basis and regulation of OTULIN-LUBAC interaction. Mol. Cell 54 (2014), 335–348.
9. Emmerich, C.H., Ordureau, A., Strickson, S., Arthur, J.S., Pedrioli, P.G., Komander, D., Cohen, P., Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl. Acad. Sci. USA 110 (2013), 15247–15252.
10. Fiil, B.K., Gyrd-Hansen, M., Met1-linked ubiquitination in immune signalling. FEBS J. 281 (2014), 4337–4350.
11. Gerlach, B., Cordier, S.M., Schmukle, A.C., Emmerich, C.H., Rieser, E., Haas, T.L., Webb, A.I., Rickard, J.A., Anderton, H., Wong, W.W., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471 (2011), 591–596.
12. Haas, T.L., Emmerich, C.H., Gerlach, B., Schmukle, A.C., Cordier, S.M., Rieser, E., Feltham, R., Vince, J., Warnken, U., Wenger, T., et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36 (2009), 831–844.
13. Harhaj, E.W., Dixit, V.M., Regulation of NF-κB by deubiquitinases. Immunol. Rev. 246 (2012), 107–124.
14. Hitomi, J., Christofferson, D.E., Ng, A., Yao, J., Degterev, A., Xavier, R.J., Yuan, J., Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135 (2008), 1311–1323.
15. Ikeda, F., Deribe, Y.L., Skånland, S.S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M., van Wijk, S.J., Goswami, P., Nagy, V., Terzic, J., et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471 (2011), 637–641.
16. Iwai, K., Fujita, H., Sasaki, Y., Linear ubiquitin chains: NF-κB signalling, cell death and beyond. Nat. Rev. Mol. Cell Biol. 15 (2014), 503–508.
17. Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K., Iwai, K., A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25 (2006), 4877–4887.
18. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., Courtois, G., The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424 (2003), 801–805.
19. Kupka, S., Reichert, M., Draber, P., Walczak, H., Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death. FEBS J. 283 (2016), 2626–2639.
20. Ling, A., Soares, F., Croitoru, D.O., Tattoli, I., Carneiro, L.A., Boniotto, M., Benko, S., Philpott, D.J., Girardin, S.E., Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3. J. Biol. Chem. 287 (2012), 28705–28716.
21. Mathis, B.J., Lai, Y., Qu, C., Janicki, J.S., Cui, T., CYLD-mediated signaling and diseases. Curr. Drug Targets 16 (2015), 284–294.
22. Moquin, D.M., McQuade, T., Chan, F.K., CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS ONE, 8, 2013, e76841.
23. Newton, K., Manning, G., Necroptosis and Inflammation. Annu. Rev. Biochem. 85 (2016), 743–763.
24. O'Donnell, M.A., Perez-Jimenez, E., Oberst, A., Ng, A., Massoumi, R., Xavier, R., Green, D.R., Ting, A.T., Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 13 (2011), 1437–1442.
25. Onisto, M., Slongo, L.M., Graziotto, R., Zotti, L., Negro, A., Merico, M., Moro, E., Foresta, C., Evidence for FSH-dependent upregulation of SPATA2 (spermatogenesis-associated protein 2). Biochem. Biophys. Res. Commun. 283 (2001), 86–92.
26. Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B., Shimizu, Y., Sarr, A., Draberova, H., Montinaro, A., et al. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9 (2014), 153–165.
27. Reiley, W.W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K.B., Norbury, C.C., Sun, S.C., Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat. Immunol. 7 (2006), 411–417.
28. Saggar, S., Chernoff, K.A., Lodha, S., Horev, L., Kohl, S., Honjo, R.S., Brandt, H.R., Hartmann, K., Celebi, J.T., CYLD mutations in familial skin appendage tumours. J. Med. Genet. 45 (2008), 298–302.
29. Schaeffer, V., Akutsu, M., Olma, M.H., Gomes, L.C., Kawasaki, M., Dikic, I., Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling. Mol. Cell 54 (2014), 349–361.
30. Sedger, L.M., McDermott, M.F., TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 25 (2014), 453–472.
31. Takiuchi, T., Nakagawa, T., Tamiya, H., Fujita, H., Sasaki, Y., Saeki, Y., Takeda, H., Sawasaki, T., Buchberger, A., Kimura, T., Iwai, K., Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes Cells 19 (2014), 254–272.
32. Tauriello, D.V., Haegebarth, A., Kuper, I., Edelmann, M.J., Henraat, M., Canninga-van Dijk, M.R., Kessler, B.M., Clevers, H., Maurice, M.M., Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol. Cell 37 (2010), 607–619.
33. Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S., Tanaka, K., Nakano, H., Iwai, K., SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471 (2011), 633–636.
34. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., Mosialos, G., CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424 (2003), 793–796.
35. Wagner, S.A., Satpathy, S., Beli, P., Choudhary, C., SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes. EMBO J., 2016, e201694300, 10.15252/embj.201694300.
36. Walczak, H., Iwai, K., Dikic, I., Generation and physiological roles of linear ubiquitin chains. BMC Biol., 10, 2012, 23.
37. Wertz, I.E., TNFR1-activated NF-κB signal transduction: regulation by the ubiquitin/proteasome system. Curr. Opin. Chem. Biol. 23 (2014), 71–77.
38. Wright, A., Reiley, W.W., Chang, M., Jin, W., Lee, A.J., Zhang, M., Sun, S.C., Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Dev. Cell 13 (2007), 705–716.
39. Yau, R., Rape, M., The increasing complexity of the ubiquitin code. Nat. Cell Biol. 18 (2016), 579–586.
40. Zhang, J., Stirling, B., Temmerman, S.T., Ma, C.A., Fuss, I.J., Derry, J.M., Jain, A., Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116 (2006), 3042–3049.
41. Zhang, M., Lee, A.J., Wu, X., Sun, S.-C., Regulation of antiviral innate immunity by deubiquitinase CYLD. Cell. Mol. Immunol. 8 (2011), 502–504.
42. Zinngrebe, J., Montinaro, A., Peltzer, N., Walczak, H., Ubiquitin in the immune system. EMBO Rep. 15 (2014), 28–45.